Mindset Pharma Performance
| MSSTFDelisted Stock | USD 0.36 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.84, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Mindset Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mindset Pharma is expected to be smaller as well. Mindset Pharma right now secures a risk of 0.0%. Please verify Mindset Pharma maximum drawdown, as well as the relationship between the expected short fall and day median price , to decide if Mindset Pharma will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Mindset Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Mindset Pharma is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 6.6 M | |
| Free Cash Flow | 385.6 K |
Mindset |
Mindset Pharma Relative Risk vs. Return Landscape
If you would invest 36.00 in Mindset Pharma on September 5, 2024 and sell it today you would earn a total of 0.00 from holding Mindset Pharma or generate 0.0% return on investment over 90 days. Mindset Pharma is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Mindset, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Mindset Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mindset Pharma's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Mindset Pharma, and traders can use it to determine the average amount a Mindset Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MSSTF |
Based on monthly moving average Mindset Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mindset Pharma by adding Mindset Pharma to a well-diversified portfolio.
Mindset Pharma Fundamentals Growth
Mindset OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Mindset Pharma, and Mindset Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mindset OTC Stock performance.
| Return On Equity | -2.43 | |||
| Return On Asset | -0.48 | |||
| Profit Margin | (1.64) % | |||
| Operating Margin | (1.33) % | |||
| Current Valuation | 19.22 M | |||
| Shares Outstanding | 95.25 M | |||
| Price To Book | 28.87 X | |||
| Price To Sales | 4.83 X | |||
| Revenue | 3.91 M | |||
| EBITDA | (16.53 M) | |||
| Cash And Equivalents | 8.71 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 171.79 K | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 385.56 K | |||
| Earnings Per Share | (0.19) X | |||
| Total Asset | 9.77 M | |||
About Mindset Pharma Performance
By analyzing Mindset Pharma's fundamental ratios, stakeholders can gain valuable insights into Mindset Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mindset Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mindset Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. The company was founded in 2019 and is based in Toronto, Canada. Mindset Pharma is traded on OTC Exchange in the United States.Things to note about Mindset Pharma performance evaluation
Checking the ongoing alerts about Mindset Pharma for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Mindset Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mindset Pharma is not yet fully synchronised with the market data | |
| Mindset Pharma has some characteristics of a very speculative penny stock | |
| Mindset Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 3.91 M. Net Loss for the year was (16.61 M) with profit before overhead, payroll, taxes, and interest of 3.91 M. |
- Analyzing Mindset Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mindset Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Mindset Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mindset Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mindset Pharma's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Mindset Pharma's otc stock. These opinions can provide insight into Mindset Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |